One of the most dreaded feelings for an investor is when the stock they just bought is overvalued, or they missed out on an undervalued opportunity by not acting fast enough.
But what if you had the insights to effectively evaluate a company like Medifast Inc before investing? Investing requires a certain perspective to avoid being overly confident in a company or worried about cyclical changes. A smart way to take the guesswork out of knowing when to buy or sell Medifast Inc’s stock is to have the right tools and resources as well as a clear monitoring process.
In this article, we go over a few key elements for understanding Medifast Inc’s stock price such as:
- Current stock price and volume
- Stock price history
- Upgrades and downgrades from analysts
- Stock price momentum as measured by its relative strength
About Medifast Inc
(MED)
Before we jump into Medifast Inc’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.
Medifast, Inc. (Medifast) is a health and wellness company. The Company sells a variety of weight loss, weight management and healthy living products all based on its proprietary formulas under the OPTAVIA, Optimal Health by Take Shape for Life, and Flavors of Home brands. Medifast?s product line includes more than 65 consumable options, including, but not limited to, bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups. OPTAVIA coaches also counsel their customers on how to develop healthy habits, such as preparing lean and green meals and choosing healthy snacks. Medifast nutritional products are formulated with high-quality ingredients. Medifast?s wholly owned subsidiaries include Jason Pharmaceuticals, Inc., OPTAVIA, LLC, Jason Enterprises, Inc., Jason Properties, LLC, Seven Crondall Associates, LLC, Corporate Events, Inc., OPTAVIA (Hong Kong) Limited, and OPTAVIA (Singapore) PTE. LTD
Want to learn more about Medifast Inc’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Medifast Inc. The AAII Stock Evaluator puts a company’s grades, charts, news, financials, valuation, ratios, filings and more at your fingertips.
Medifast Inc’s Stock Price as of Market Close
As of March 31, 2023, 4:00 PM CST, Medifast Inc’s stock price was $103.67.
Medifast Inc is up 5.09% from its previous closing price of $98.65.
During the last market session, Medifast Inc’s stock traded between $98.46 and $100.49. Currently, there are 10.91 million shares of Medifast Inc stock available for purchase.
Medifast Inc’s price-earnings (P/E) ratio is currently at 7.8, which is low compared to the Food Processing industry median of 20.2. The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share.
Medifast Inc Stock Price History
Medifast Inc’s
(MED) price is currently down 7.54% so far this month.
During the month of March, Medifast Inc’s stock price has reached a high of $114.65 and a low of $96.33.
Over the last year, Medifast Inc has hit prices as high as $197.19 and as low as $96.00. Year to date, Medifast Inc’s stock is down 50.5%.
Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions
What Caused Medifast Inc Stock’s Price to Rise?
Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?
One of the most common factors that can drastically impact a stock’s price is analyst upgrades and downgrades. When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of March 30, 2023, there was 1 analyst who downgraded Medifast Inc’s stock and 0 analysts who upgraded over the last month.
Additionally, you'll want to evaluate Medifast Inc’s financial health and valuation. It is possible for a stock to appear cheap based on one valuation metric but appear expensive on another. It is also possible for one valuation ratio to be associated with outperforming stocks during certain periods of time but not others.
Therefore, AAII developed a composite valuation to help resolve such issues. AAII’s Value Grade analyzes six distinct variables: price-to-sales (P/S) ratio, price-earnings (P/E) ratio, the ratio of enterprise value to earnings before interest, taxes, depreciation and amortization (EV/EBITDA), shareholder yield, price-to-book-value (P/B) ratio and price-to-free-cash-flow (P/FCF) ratio.
Medifast Inc’s current valuation based on AAII’s Value Grade is a B, which means it is considered to be Value.
Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.
Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Medifast Inc
(MED) by visiting AAII Stock Evaluator.
Relative Price Strength of Medifast Inc
Relative price strength addresses the relationship between a stock price’s trend and the price trend of the market. This ratio is expressed as a percentage and helps investors understand a company’s momentum as well as its value. You can use relative price strength to select investments that have been outperforming the market or a specific benchmark.
For AAII’s Momentum Grade, a weighted relative price strength is calculated. The weighted four-quarter relative price strength rank is the relative price change for each of the past four quarters. The most recent quarterly price change is given a weight of 40%, and each of the three previous quarters are given a weighting of 20%.
As of March 30, 2023, Medifast Inc has a weighted four-quarter relative price strength of -8.95%, which translates to a Momentum Score of 29 and is considered to be Weak.
Want to learn more about how Medifast Inc is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.
Medifast Inc Stock Price: Bottom Line
As of March 31, 2023, Medifast Inc’s stock price is $103.67, which is up 5.09% from its previous closing price.
At AAII, we stress that investors should never buy or sell a stock solely based on its stock price. Past returns do not guarantee future performance. Therefore, you should consider multiple ratios, fundamentals and analytics before making a decision. Whether you decide it’s a good time to buy or sell Medifast Inc’s stock based on its stock price forecast is ultimately up to you.
It’s important to understand that stock prices are driven by a variety of factors, but ultimately the price at any given moment is due to the supply and demand in the market. Stock price overviews, like the one you just read, only give you a small snapshot of a company’s performance, value and momentum.
By becoming an A+ Investor subscriber, you will have full access to analytics, grades, stock screens, commentary and more so you can invest with confidence.
Included With AAII Platinum
Screen: 23.7%
Annual Gain Since Inception. Data as of 12/31/2024.
769.3% Stock Superstars Portfolio Total Return Since Inception
U.S. Index ETF (IYY)
SSR Group 3 O'Shaughnessy portfolio has a 411.2% gain since inception performance compared to IYY at only 119.1%% Performance as of 11/29/24.
FREE REPORT
BECOME A MEMBER FOR ONLY $2
Get access to powerful investment discovery tools and a wealth of investment education to help you achieve your financial goals.